Vaping-related lung illnesses have risen to 530 cases; 2 invasive species of mosquitoes are spreading across California; US pays $3 million toward research on medicinal marijuana.
The incidence of mysterious lung illnesses related to vaping has increased to 530 reported cases across 38 states, according to The Washington Post. The outbreak of vaping-related illnesses has now accounted for 8 deaths across the nation, leading to intervention by the FDA. Federal officials said that the enforcement arm of the FDA has been conducting a probe in parallel with the public health investigation led by the CDC. The root cause of these illnesses and deaths has yet to be found, but officials disclosed that all reported cases show a history of e-cigarette or vaping use. Many of the affected individuals had a history of using e-cigarette products containing tetrahydrocannabinol (THC), the psychoactive compound that produces marijuana’s high, as well as many reported cases involving vaping both nicotine and THC, and some reporting vaping solely nicotine products.
Invasive species of mosquitoes carrying Zika, dengue, yellow fever, and other dangerous viruses are spreading across California, with 2 species currently found. California Healthline reported that these mosquitoes have been found as far north as Sacramento and Placer counties, which now brings the total to 16 counties containing Aedes aegypti, the mosquito species that causes yellow fever. Of these counties, 5 have additionally detected the species Aedes albopictus, known as the Asian tiger mosquito. These mosquitoes can spread the Zika virus, which created an epidemic in 2015 within Brazil and can be sexually transmitted after infection. Microcephaly, a condition which inhibits the development of a baby’s brain and causes their head to be much smaller than usual, is a known effect of the Zika virus.
Researchers will receive federal grants to study the effectiveness of cannabidiol (CBD), a component in marijuana, for relieving pain, according to the Associated Press. The US government will spend $3 million in total, allocated as 9 research grants, on testing CBD and many other lesser-known chemicals, but it notably excluded THC as part of its research. Marijuana is currently still considered an illegal drug by the federal government, but it is now allowed for medicinal purposes in 30 states. Delineating which chemical components in marijuana result in the highest effectiveness for treating chronic pain, and additionally whether these chemicals can eliminate the need for THC, are key objectives for research.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
2 Commerce Drive
Cranbury, NJ 08512